Table 1 Selection criteria for studies to be included in systematic review assessing the incidence of TB and MDR-TB and the therapeutic outcomes among paediatrics
From: The incidence of TB and MDR-TB in pediatrics and therapeutic options: a systematic review
Item | Inclusion criteria | Exclusion criteria |
|---|---|---|
Population | -Studies involving paediatrics ≤15 years. -Studies including both male and female patients. | Studies involving -Participants ≥15 years -Pregnant participants -Participants with multi-morbidities |
Intervention / Investigated condition | The review will be assessing the incidence of TB and MDR-TB among the paediatric population and the therapeutic options available. | -Studies describing combined treatment of more than 2 diseases (TB or MDR-TB /HIV) |
Comparison /Context | -Studies conducted in paediatric patients globally -Studies conducted in paediatric patients of all cultural backgrounds | |
Outcome | -Studies assessing the incidence of TB and MDR-TB among the paediatric population. -Studies assessing the therapeutic options available to treat TB and MDR-TB in terms of the dosage forms available. | Studies describing outcomes that are unrelated to the incidence and treatment of TB and MDR-TB |
Type of studies | Cohort studies that use quantitative research methods and Observation studies | -Mini-reviews, conference abstracts, letters to editors, editorials, commentaries. -Studies without an abstract -Studies whose full data will not be available even upon requesting from the author -Duplicates studies: for studies published with the same or different titles or in more than one journal, the most updated version shall be considered. |